title: Prenatal dopamine and neonatal behavior and biochemistry.
abstract: Depressed pregnant women (N=126) were divided into high and low prenatal maternal dopamine (HVA) groups based on a tertile split on their dopamine levels at 20 weeks gestation. The high versus the low dopamine group had lower Center for Epidemiological Studies-Depression Scale (CES-D) scores, higher norepinephrine levels at the 20-week gestational age visit and higher dopamine and serotonin levels at both the 20- and the 32-week gestational age visits. The neonates of the mothers with high versus low prenatal dopamine levels also had higher dopamine and serotonin levels as well as lower cortisol levels. Finally, the neonates in the high dopamine group had better autonomic stability and excitability scores on the Brazelton Neonatal Behavior Assessment Scale. Thus, prenatal maternal dopamine levels appear to be negatively related to prenatal depression scores and positively related to neonatal dopamine and behavioral regulation, although these effects are confounded by elevated serotonin levels.
authors.affiliation: Touch Research Institutes, University of Miami Medical School, Miami, FL 33101, USA. tfield@med.miami.edu
authors.forename: Tiffany
authors.initials: T
authors.lastname: Field
authors.forename: Miguel
authors.initials: M
authors.lastname: Diego
authors.forename: Maria
authors.initials: M
authors.lastname: Hernandez-Reif
authors.forename: Barbara
authors.initials: B
authors.lastname: Figueiredo
authors.forename: Osvelia
authors.initials: O
authors.lastname: Deeds
authors.forename: Angela
authors.initials: A
authors.lastname: Ascencio
authors.forename: Saul
authors.initials: S
authors.lastname: Schanberg
authors.forename: Cynthia
authors.initials: C
authors.lastname: Kuhn
mesh_terms: D000328:Adult; D003866:Depressive Disorder / Q000175:diagnosis / Q000523:psychology / Q000652:urine; D004298:Dopamine; D005260:Female; D006801:Humans; D018730:Infant Behavior / Q000502:physiology* / Q000523:psychology*; D007231:Infant, Newborn; D011247:Pregnancy; D011248:Pregnancy Complications / Q000523:psychology* / Q000652:urine*; D011295:Prenatal Care / Q000379:methods; D011297:Prenatal Exposure Delayed Effects / Q000523:psychology* / Q000652:urine*; D055815:Young Adult
chemical_list: D004298:Dopamine
references.citation: J Child Psychol Psychiatry. 2001 Sep;42(6):777-83
references.pmid: 11583250
references.citation: Acta Psychiatr Scand Suppl. 2005;(427):14-21
references.pmid: 15877719
references.citation: Am J Psychiatry. 1980 Sep;137(9):1081-4
references.pmid: 7425160
references.citation: Psychoneuroendocrinology. 2006 Aug;31(7):876-88
references.pmid: 16769179
references.citation: J Clin Psychiatry. 2006;67 Suppl 6:3-8
references.pmid: 16848670
references.citation: Psychiatry. 2004 Spring;67(1):63-80
references.pmid: 15139586
references.citation: Prog Neuropsychopharmacol Biol Psychiatry. 2006 May;30(3):531-4
references.pmid: 16414168
references.citation: Hum Psychopharmacol. 2006 Mar;21(2):91-9
references.pmid: 16444772
references.citation: Curr Drug Targets. 2006 Feb;7(2):177-85
references.pmid: 16475959
references.citation: Mol Psychiatry. 1998 May;3(3):238-46
references.pmid: 9672899
references.citation: Monogr Soc Res Child Dev. 1978;43(5-6):1-13
references.pmid: 752799
references.citation: Metabolism. 2005 May;54(5 Suppl 1):24-7
references.pmid: 15877309
references.citation: J Child Psychol Psychiatry. 2006 Nov;47(11):1143-51
references.pmid: 17076753
references.citation: J Clin Psychiatry. 2006;67 Suppl 6:27-32
references.pmid: 16848674
references.citation: J Neurosci Methods. 1984 Sep;11(4):257-73
references.pmid: 6513585
references.citation: Fundam Clin Pharmacol. 2004 Dec;18(6):601-7
references.pmid: 15548230